(Q28248361)
Statements
Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial (English)
0 references
January 2012
0 references
46
0 references
1
0 references
64-71
0 references